, Tracking Stock Market Picks
Enter Symbol:
Keryx Biopharmaceuticals, Inc. (KERX) [hlAlert]

down 89.67 %

Keryx Biopharmaceuticals, Inc. (KERX) rated Underperform by Bear Stearns

Posted on: Monday,  Mar 10, 2008  8:25 AM ET by Bear Stearns

Bear Stearns rated Underperform Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on 03/10/2008, when the stock price was $0.64. Since
then, Keryx Biopharmaceuticals, Inc. has gained 868.75% as of 01/12/2016's recent price of $6.20.
If you would have followed this Bear Stearns's recommendation on KERX, you would have lost 89.67% of your investment in 2864 days.

Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.

The Bear Stearns Companies Inc. (NYSE: BSC) is the parent company of Bear, Stearns & Co. Inc., a leading global investment banking, securities trading and brokerage firm. Since 1923, we have helped corporations, institutions, governments and individuals reach their financial objectives. Clients have come to rely on the breadth of our expertise, our commitment to client service and our innovative approach to problem-solving. Talented professionals join Bear Stearns because of our unique corporate culture. Based on respect, integrity, meritocracy, innovation and a commitment to philanthropy, these guiding principles serve as blueprint for the way that we do business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/10/2008 8:25 AM Sell
as of 12/24/2008
1 Week down  -27.77 %
1 Month down  -64.28 %
3 Months   
1 YTD down  -4.54 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy